SEC Form D filing
Cue Biopharma, Inc.
Biotech · Series B · Regulation D 506(b) · MA · Filed May 14, 2026
- Offering amount
- $30.0M
- Exemption
- Reg D 506(b)
- Issuer state
- MA
- Filing date
- May 14, 2026
- Signature date
- May 14, 2026
- CIK
- 0001645460
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Summary
Auto-generated$30M Cue Biopharma immunotherapy clear biotech in series-b range; established clinical-stage company.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.